Stay updated on Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    - Revision updated from v3.3.3 to v3.3.4.
    Difference
    0.0%
    Check dated 2026-01-17T04:55:09.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Expanded the Locations section with numerous site entries across multiple regions, and updated the page revision from v3.3.2 to v3.3.3.
    Difference
    3%
    Check dated 2025-12-19T16:13:42.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2, indicating a software update, with no changes to study content or data; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-28T06:00:37.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision history shows the addition of Revision: v3.3.1 and the deletion of Revision: v3.2.0, and no study details or user-facing content are affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-21T02:16:48.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The funding/status notice regarding government operations has been removed from the page. It previously informed users about potential delays and where to check for updated operating status.
    Difference
    0.2%
    Check dated 2025-11-13T22:54:12.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    No additions or deletions were detected; the page content appears unchanged.
    Difference
    0.3%
    Check dated 2025-10-30T14:46:56.000Z thumbnail image

Stay in the know with updates to Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immune-Target Combo in 2L+ Renal Cell Carcinoma Clinical Trial page.